Rationale The opioid peptide β-endorphin (β-E) is synthesized by the pro-opiomelanocortin gene in response to environmental stressors and alcohol administration and is implicated in the behavioral sequelae associated with these stimuli. Objectives We sought to determine the influence of β-E on the stress response by evaluating basal measures of anxiety as well as on EtOH-induced anxiolytic behavior using transgenic mice that differ with respect to β-E. Methods Anxious behavior was evaluated for male and female heterozygous, wild-type, and β-E knockout mice using the Light-Dark Box and Plus Maze assays. Subsequent tests evaluated behavior 20 min after administration of intraperitoneal saline or EtOH (0.5, 1.0, and 1.5 g/kg). Results We observed a direct relationship between β-E levels and the percentage of entries into open arms of the Plus Maze as well as the time spent in either the open arms or the light compartment of the Light-Dark box during basal conditions, suggesting that this peptide normally inhibits anxious behavior. However, mice lacking β-E demonstrated an exaggerated anxiolytic response to EtOH in these assays. Conclusions These data suggest that β-E moderates the response to stressful stimuli and supports the hypothesis that this peptide influences the behavioral effects of EtOH.
Introduction β-endorphin (β-E) is a 31 amino-acid peptide that is cleaved from the carboxyl terminus of the Proopiomelanocortin (POMC) gene. As a member of the large family of opioid peptides that are widely and differentially distributed throughout the nervous system, it has been implicated in a variety of behaviors including the regulation of pain and reward, as well as in modulating neurocircuitry involved in learning and memory, motivation and processes associated with stress, fear, or anxiety (e.g., Bloom 1980) . The response to stressors involves a complex cascade of endocrine, autonomic, and behavioral changes that seem to be generally aimed at maintaining or restoring homeostasis. At least in part because of its complexity, neither a precise definition nor thorough knowledge of the neurobiological underpinnings of the stress response has been elucidated (Pacak and Palkovitis 2001) . Nonetheless, nearly any operational understanding includes activation of the hypothalamic-pituitary-adrenal (HPA) axis. This reaction involves secretion of corticotrophin-releasing hormone (CRH) from the hypothalamus leading to adrenocorticotropic hormone (ACTH) release into the bloodstream and subsequent glucocorticoid secretion from the adrenal glands, contributing to the behavioral fight or flight response. Corticotropin-releasing hormone in both the hypothalamus and pituitary stimulates POMC gene expression which is initially cleaved into two subunits, one of which eventually gives rise to ACTH and the other which may yield β-E (Pfaff et al. 2004) .
The most well-studied effect of β-E is its ability to modulate pain, but an early report by Fratta et al. (1981) suggested that central administration of β-E produced opposite effects to that of ACTH administration ("reciprocal antagonism") on several behaviors in rats including cataplexy, rigidity, and analgesia and supported the notion that β-E is directly implicated in the homeostatic regulation of ACTH response. Indeed, β-E synthesis and release is precipitated by stressful stimuli (Guillemin et al. 1977; Oltras et al. 1987) , and low doses of β-E have been shown to decrease stress responding (Panksepp 2003) . Modulation of the behavioral response to stressful stimuli by β-E is discussed in a recent review by Ribiero et al. (2005) and previously by Yamada and Nabeshima (1995) .
Corticotropin-releasing hormone is the primary regulator of POMC peptides, and ethanol (EtOH) exposure leads to CRH release in vivo (Redei et al. 1988 ) and in vitro (deWaele and Gianoulakis 1993) . Thus, acute EtOH, like exposure to classic stressors, increases the synthesis and release of ACTH and β-E (Froehlich et al. 1990 (Froehlich et al. , 2000 Gianoulakis 1990; Marinelli et al. 2004; Millan 1981; Olive et al. 2001; Rivier 1996; Sarkar et al. 2007; Scanlon et al. 1992; Schulz et al. 1980; Thiagarajan et al. 1988 Thiagarajan et al. , 1989 . Paradoxically though, one of the primary factors influencing alcohol ingestion is thought to be stress reduction, particularly in genetically or environmentally prone individuals (see Cappell and Herman 1972; Pohorecky 1991 for reviews) .
Although the relationship between EtOH consumption and the sequelae associated with stress is naturally complex (as each, independently, are highly multidimensional), there is a large body of empirical research evincing the anxiolytic effects of EtOH (Eckardt et al. 1998; Gianoulakis et al. 2003; Grobin et al. 1998; LaBuda and Fuchs 2001) . Furthermore, some stressors have been shown to increase self-administration of EtOH (e.g., Eckardt et al. 1998; Mollenauer et al. 1993; Wolffgramm 1990 ) and inhibiting the stress axis via CRH antagonism reduces EtOH consumption (Lê et al. 2000; Funk et al. 2006 ). In the clinic, alcoholism and anxiety disorders are frequently comorbid (Kushner et al. 1990; Bradizza et al. 2006; Conway et al. 2006; Fein et al. 2007; Vendruscolo et al. 2006) , and a significant proportion of alcohol-dependent individuals report that alcohol is reinforcing because it reduces anxiety (Barrenha and Chester 2007; Hill and Angel 2005; Koven et al. 2005; Lawyer et al. 2002) . Thus, the stress-attenuating properties of EtOH likely contribute to its reinforcing effects, and these may be mediated by β-E.
We chose to directly assess the impact of β-E on behavior associated with anxiety, as well as the anxiolytic effects of EtOH, by evaluating transgenic mice that have been engineered to lack β-E. These mice were developed over a decade ago in the laboratory of Malcolm Low (Rubinstein et al. 1996) and have been evaluated for differences in pain responses and energy balance (Appleyard et al. 2003; Hayward et al. 2006; Mogil et al. 2000) as well as sensitivity to cocaine and morphine (Marquez et al. 2008 ). In addition, we have looked at oral selfadministration of EtOH (Grisel et al. 1999 and Williams et al. 2007 ) where heterozygote mice, possessing half of the normal levels of β-E, generally drink slightly more than either wild-type controls or mice totally lacking this peptide. Beside the direct correlation between gene and peptide concentration, no differences have been found in other POMC peptides or in opioid receptor levels across genotypes (Mogil et al. 2000; Rubinstein et al. 1996) . In order to further evaluate the effects of β-E on behavior and pharmacology, we studied three lines of mice with differing levels of β-E in the Plus Maze and Light-Dark tests, both under basal conditions and following EtOH administration.
Method
Subjects were adult male and female wild-type controls (C57BL/6J; B6), β-E deficient (KO), and heterozygous (HT) mice bred in-house from progenitors obtained from the Jackson Laboratories (Bar Harbor, ME, USA). The gene mutation has been fully backcrossed to the C57BL/6J strain (>20 generations). HT mice were bred from KO males and B6 females; others were bred under identical conditions from genotype-matched pairs. These subjects were housed two to five per Plexiglas cage following weaning at 20 to 21 days with sex-matched siblings. The ventilated colony room maintained a constant light schedule (12-h reverse light-dark cycle with lights on 1,900 h) and a temperature of 22±2°C. Water and food (Lab Diet 5015) were available ad libitum. All subjects were between 50 and 75 days of age at the time of testing, and each subject was tested only one time. Throughout experimentation, subject order was counterbalanced with regard to genotype, sex, and drug. Behavioral assessment of genotypic differences may be facilitated by testing during the animal's active phase (Hossain et al. 2004 ) and so occurred between 9 a.m. and 6 p.m. In all experiments, data were recorded by an experimenter blind to drug condition and genotype. In addition, all procedures were carried out in accordance with the National Institutes of Health guidelines and were approved by the Animal Care and Use Committee of Furman University.
Experimental apparatus
The elevated Plus Maze, made from Plexiglas, was raised approximately 45 cm from ground level. The perimeter of the base of the maze was enclosed with a clear 15 cm tall wall; the area of the base was filled with wood shavings. The floor of the elevated portion of the maze was black. Two opposite arms (30×5 cm each) of the maze were enclosed by a clear 10 cm high Plexiglas wall, and the remaining two arms were "open", with a very short (2 mm) wall. A center space (5 cm 2 ) between these four arms was also not enclosed. The elevated portion of the apparatus was cleaned with a dilute detergent between each session.
The Light-Dark Box was composed of two Plexiglas chambers of equal size (25 cm 3 ) that shared a common wall. The bottom of the entire apparatus was constructed of black, opaque Plexiglas, as were the four walls of the dark chamber. A 27-cm 2 panel of the same black Plexiglas served as a top for the dark side of the apparatus. The three walls of the light side were constructed of clear Plexiglas, as was the top panel; the fourth wall of the light chamber was black, as it was shared with the dark chamber. A square hole (2.5 cm 2 ) in the bottom center of the wall shared by both chambers allowed subjects to pass freely between light and dark chambers. Between each subject's test session, the apparatus was cleaned using a sponge filled with a dilute, low-residue detergent.
Experiment 1
Animals (KO n=10, HT n=11, B6 n=11) were removed from the colony room, marked and weighed, and allowed 45-60 min to acclimate to conditions in an experimental room before testing. This room was lit with fluorescent ceiling lights as well as natural light from a single window and, thus, contrasted with the colony room (dark phase). Though this abrupt transition may have altered chemical or behavioral function, we wanted to test subjects during their active phase; moreover, maze behavior is routinely assessed in well-lit conditions as results may depend upon lighting (Costall et al. 1989) . Experiment 1 subjects received no injections but were placed in individual housing for 20 min after habituation and before testing (to parallel methods used in experiments involving drug administration; because saline and EtOH-injected animals are generally taken from the same cage, we wanted to avoid possible confounds from differential interaction between cage mates following injection). After this 20-min period, they were lifted by the tail and placed gently into a closed arm facing the center of the maze. For the following 5 min, the number of open arm entries, closed arm entries, time spent in open arms, closed arms, and center area were recorded by a blind observer seated about 1 M from the maze. Entry into an arm was defined as all four feet crossing into the region. From these data, the percentage of arm entries in to open arms was calculated as a measure of anxious behavior corrected for general locomotor activity.
Experiment 2
The procedure for this experiment mimicked that of "Experiment 1" with the exception that animals received intraperitoneal (IP) injections of either saline, 0.5, 1.0, or 1.5 g/kg 20% EtOH v/v (KO n=11, 10, 11, and 9, respectively, B6 n=9, 9, 7, and 7) after about 45 min of acclimation. Immediately following injection, subjects were individually housed for 20 min and then placed onto the Plus Maze where behavior was evaluated, as in "Experiment 1," for 5 min. Because the primary purpose of this study was to evaluate a range of EtOH doses to inform subsequent testing (Exp 3 and 5), heterozygote mice were not assessed.
Experiment 3
The procedure for this experiment paralleled those used in "Experiment 2" with the exception that each of the three genotypes was tested following IP injections of 1.5 g/kg 20% EtOH v/v (KO n=13, HT n=10, B6 n=14) or equivolume saline (KO n=13, HT n=12, B6 n=14) after 45 min of acclimation and before 20 min of individual housing. This dose was chosen based on the results of "Experiment 2." Experiment 4
Experiment 4 was similar to "Experiment 1" except that behavioral testing took place in the Light-Dark box. Subjects (KO n=10, HT n=8, B6 n=7) were removed from the colony room, marked, and weighed and allowed 45 min to acclimate to experimental conditions before testing. The testing room was lit with fluorescent ceiling lights as well as natural light from a single window and, thus, contrasted with the colony room (dark phase). A 60-W halogen lamp was also affixed above the light side of the apparatus to ensure optimal contrast between light and dark chambers (to facilitate discrimination between the two chambers). Again, we wanted to test subjects during their active phase, and this test is conventionally done in bright conditions. Experiment 4 subjects received no injections but were individually housed for 20 min before testing. After this period, they were placed into the dark side of the Light-Dark Box facing the wall opposite the opening into the light chamber. The dark chamber was immediately covered and behavior was recorded over a 5-min period by an experimentally blind, silent observer seated approximately 1 M from the experimental apparatus. Latency to emerge from the dark chamber, number of crossings between chambers (defined as all four feet across the boundary), and total time spent in the light chamber were recorded.
Experiment 5
Procedure for this experiment was as described for "Experiment 4" with the exception that all subjects received IP injections of either 1.5 g/kg 20% EtOH v/v (KO n=9, HT n=11, B6 n=11) or equivolume saline (KO n=12, HT n=14, B6 n=11) before being placed into individual housing for 20 min. A dose of 75 g/kg EtOH was also evaluated but produced no effects substantially differing from saline; those data are not included.
Experiment 6
As an additional measure of stress reactivity, we assessed adrenal gland weight in mice of each genetic line. Briefly, mice were sacrificed by cervical dislocation, and both adrenal glands were located, removed, and weighed (together). The experimenter was blind to genotype in all cases. There was a total N of 143: 56 KOs, 59B6s, and 28 HTs. Many of the adrenal glands were taken after experimental manipulation (at least 1-2 weeks post manipulation), but about 30% were experimentally naïve (approximately equally divided across genotypes).
Statistical analysis
Data were analyzed separately for each experiment by factorial analysis of variance (ANOVA) in SYSTAT: first by genotype, sex, and drug (where appropriate) and, then, in the absence of interactions with sex, collapsing across this factor. Significant main effects and interactions were investigated further using Tukey's HSD test for post hoc comparisons. In all cases, the criterion for significance (α level) was set at p<0.05.
Results
There were no significant interactions with sex in any of the data analyses, and so this factor was excluded from subsequent analysis and results. Another way of looking at the data is to evaluate the percentage of time spent in open arms as a function of total arm time (in other words, controlling for time spent in the center of the maze). In our analysis, the F statistic was virtually identical in both cases (for percentage of open time, F (2,29) =4.917, p<0.05), so the more conservative raw data are depicted in Fig. 1a . KOs also evidenced a smaller percentage of entries into open arms than B6s (as did HTs; Fig. 1b, F (2,29) = 10.416, p< 0.05), but there were no significant genotypic differences in total arm entries (Fig. 1c, p=0.136 ) a measure of general locomotor activity.
Experiment 2
Results were quite different following EtOH administration (Experiment 2), in which mice lacking β-E demonstrated an exaggerated anxiolytic and locomotor response to the drug. In general, β-E deficiency resulted in a shift of the dose-response curve for EtOH to the left, indicative of increased sensitivity to the effects of EtOH on the Plus Maze. Overall, KO mice spent more time in the open arms than wild-types ( Fig. 2a; F (1,65) =5.382, p<0.05). There was also a dose effect as open time increased with increasing EtOH dose (F (3,65) =11.578, p<0.001). Notably, the interaction term was also significant (F (3,65) =2.735, p=0.051) indicative of an increased sensitivity to the anxiolytic effects of EtOH for β-E-deficient mice in this behavioral measure. Post hoc analysis showed a tendency for the KO mice to spend less time in the open arms than B6s after saline (p=0.08) but more time after 0.5 g/kg EtOH (p=0.039). Genotypes did not differ significantly on this measure after either 1.0 or 1.5 g/kg EtOH. The results were virtually identical when looking at the percentage of time spent in open arms, and so we chose to depict only the raw data.
In terms of the percentage of open arm entries in this dose-response analysis, we found the same pattern: a significant effect of genotype (F (1,65) =5.906, p<0.05) and of dose (F (3,65) =14.921, p<0.001) as well as a significant interaction (F (3,65) =3.205, p<0.05) reflecting the fact that mice deficient in β-E were especially likely to increase the percentage of entries they made into open arms following EtOH (see Fig. 2b ). Post hoc analysis indicated significant genotypic effects after saline (p=0.05; KOs<B6s) a trend following 0.5 g/kg (p=0.067) and significant differences again after 1.0 g/kg (p=0.020; KOs>B6) in that EtOH reversed the decreased likelihood of entering open arms seen in β-E deficient mice.
Finally, there were genotypic differences in locomotor activity as measured by the total number of arm entries on the Plus Maze ( Fig. 2c; F (1,65) =7.843, p<0.01). There were also significant effects of EtOH dose on this measure (F (3,65) =3.929, p<0.05) but not a significant interaction between genotype and dose (F (3,65) =1.137, p=0.34).
Experiment 3
In Experiment 3, we compared B6, HT, and KO mice on the Plus Maze after either saline or 1.5 g/kg EtOH and continued to find that low or absent β-E leads to greater EtOH-induced anxiolysis. This dose of EtOH was selected based on the results of "Experiment 2" where there were differences in behavior on the plus maze indicative of differential sensitivity to EtOH-induced anxiolysis, without differences in the locomotor response to EtOH. Indeed, these data were replicated and extended as both HTs and KOs spent more time in open arms and increased their percentage of open entries following EtOH administration, while B6s were relatively insensitive to the anxiolytic effects of this dose of EtOH in our test (Fig. 3) . A significant main effect of genotype on open time (Fig. 3(a) ; F (2,69) =4.644, p<0.05) was observed as well as an effect of drug (F (1,69) =15.564, p<0.001) and significant interaction between genotype and drug (F (2,69) =5.045, p<0.01). The same pattern was evident with respect to the percentage of open time (controlling for the time spent in the center of the maze) as both main effects showed significant differences: genotype, F (2,69) =3.665, p<0.05 and drug, F (1,69) =16.462, p<0.001. The interaction of genotype and dose was also significant: F (2,69) =5.031, p<0.01, but only the raw data are presented in Fig. 3a . Post hoc analysis of open time showed that HT and KO mice had a significant increase in this measure after EtOH (as compared to saline), and that HT mice were also spent more time in the open arms after EtOH than did B6 mice (all p<0.05). Again, β-E deficient mice evidenced an exaggerated response to EtOH with respect to the percentage of open arm entries (Fig. 3b ). There was a significant effect of genotype (F (2,69) =3.665, p<0.05), an overall effect of drug (F (1,69) =16.462, p< 0.001) as well as an interaction between genotype and EtOH F (2,69) =5.031, p<0.01). Here, too, post hoc analysis indicated significant effects of EtOH in HT and KO mice, a difference in the percentage of open arm entries following EtOH between B6 and HT mice, and, in addition, a significant difference between B6 and KO mice following saline (KOs had a lower percentage of open arm entries in this case). As shown in Fig. 3c , there were no genotypic differences in locomotor activity as measured by the total number of arm entries, nor was there any effect of 1.5 g/kg EtOH compared to saline administration on this measure or interaction between EtOH and line (all p>0.05).
Experiment 4
In Experiment 4, we evaluated behavior in the LightDark box and again found a genotype effect in which KOs took longest to emerge and B6s emerged most quickly (see Fig. 4a for means and standard errors, F (2,22) = 3.673, p<0.05). Similarly, KOs demonstrated fewer crossings into the light than B6s and HTs (Fig. 4c, F (2,22) =3.673, p<0.05). The same general trend was apparent in the amount of time each genotype spent in the light side of the box; however, these data were not significant (Fig. 4b,  p=0 .146).
Experiment 5
In Experiment 5, there was a tendency for B6 mice to emerge more quickly overall (F (2,62) =2.976, p=0.058) but no significant effects of EtOH on latency to emerge or interaction between genotype and drug (p>0.05 Fig. 5a ). However, despite the fact that KO mice spent relatively little time in the light side of the Light-Dark box in Experiment 4 and after saline injections here, they had the largest increase in this measure following IP injection of 1.5 g/kg EtOH (Fig. 2Bb) . For time spent in the light, there were significant main effects of both drug and of genotype (F (2,62) =4.479, p<0.05 and F (1,62) =10.358, p<0.05, respectively) as well as a significant interaction (F (2,62) = 4.507, p<0.05) indicative of this large change in behavior following EtOH in KO mice but not HT or B6 mice (also evidenced by significant post hoc testing where KO mice receiving saline or EtOH differed from each other). 
Fig. 5
Experiment 5 evaluated behavior in the light-dark box in B6, HT, and KO mice following either saline or 1.5 g/kg EtOH (IP). The top panel shows the latency to emerge from the dark compartment in each genotype (means ± SE), the middle panel shows the total time spent in the light compartment over the 5-min test period, and the lower panel shows the total number of light-dark crossings. Significant (p ≤ 0.05) group differences (both within and between groups) are signified by an asterisk Significant main effects of drug and genotype were observed on the variable crossings into light (F (2,62) = 6.1664, p<0.05 and F (1,62) =8.3028, p<0.05, respectively) though the interaction was not significant, indicative of the fact that KOs were generally less active than B6 mice in this test, and EtOH had a nonspecific tendency to decrease activity in this test.
Experiment 6
As an attempt to corroborate the behavioral data gleaned especially in Experiments 1A and 2A, adrenal gland weights were assessed in Experiment 3. A one-way ANOVA on strain indicated a significant effect of genotype F (2,140) =3.247, p< 0.05, and post hoc analysis revealed significant group differences between B6 and KO mice (Fig. 6) . Because some animals in each group had been manipulated experimentally, we conducted a separate ANOVA including this factor along with genotype. Because there was no significant effect of prior manipulation or interaction with this factor, data presented and analyzed are collapsed across prior experience.
Discussion
Employing two animal models of anxiety, our studies suggest that the opioid peptide β-E modulates the stress response. The elevated Plus Maze and the Light-Dark box assays were used to study the relationship between β-E and behavior, under basal conditions and following EtOH administration. In the absence of any manipulation, measures of anxious behavior (e.g., risk assessment, avoidance of open or lit areas, fewer entries into open areas) were higher in β-E deficient mice, suggesting that β-E normally attenuates the behavioral response to stress. Notably, the "hyper-anxious" state evident in mice lacking β-E was completely ameliorated following EtOH administration so that deficient mice generally displayed lower levels of anxious behavior than wild-type counterparts following EtOH administration.
The primary neural site of β-E synthesis is the ventromedial arcuate nucleus of the hypothalamus. Exposure to stressful stimuli increases β-E synthesis and release here (e.g., Constanopoulos et al. 1995; Schedlowski et al. 1995) via activation of CRH (Bronstein and Akil 1990; Poplawski et al. 2005) . Moreover, stimulation of hypothalamic β-E neurons inhibits CRH secretion from the paraventricular nucleus (Buckingham 1986; Plotsky 1991) . Because β-E circuitry in the hypothalamus is localized to cells that are responsible for stimulating CRH-mediated cortisol release from adrenal glands following exposure to a stressor (Brown 1986 ), this peptide is well situated to moderate activity of the HPA axis. Also, functional genetic variation in the μ-opioid receptor predicts the response to stressful stimuli (Chong et al. 2006 ). This circuitry fits well with the present results indicating that low or absent levels of β-E lead to an exaggerated stress response in the Plus Maze and Light-Dark assays. The fact that β-E-deficient mice also have enlarged adrenal glands further supports the contention that the stress axis is persistently overactivated in these mice (see Amario 2006 for a recent and comprehensive review of how the HPA axis transduces stressful stimuli and how this process is modified by chronic exposure). Thus, in terms of behavior and gross anatomy, our data support the notion that β-E normally functions to attenuate the stress response and that a lack of negative feedback amplifies stress activity (e.g., Sarkar et al. 2007) .
Though alcohol abuse and dependence are mediated by a complex set of environmental and genetic factors, variation in β-E is also thought to contribute to differential sensitivity to the reinforcing effects of EtOH (Cowen et al. 2004 ). The opioid-deficiency hypothesis argues that individuals at high risk for developing alcoholism may be so, in part, because of modified endorphinergic circuits (Gianoulakis 2004; Oswald and Wand 2004; ZalewskaKaszubska and Czarnecka 2005) . For instance, some studies have demonstrated lower endorphin levels in animals or humans prone to high levels of EtOH intake (Dai et al. 2005; Grisel et al. 1999; Marinelli et al. 2003; Williams et al. 2007 ). However, the mechanisms underlying the relationship between EtOH and β-E have not been clarified. One theory holds that a deficit in β-E leads to hypoactivity in the mesolimbic reward pathways and that this can be ameliorated by EtOH administration (Sher 2003; Herz 1997) . Another model emphasizes the role of the HPA axis in modifying EtOH reward. For instance, HPA functioning has been found to differ in nonalcoholic subjects with either a positive or negative family history for the disease (Hernandez-Avila et al. 2002; Wand et al. Fig. 6 Adrenal gland weights (means ± SE) in B6-, HT-, and β-Edeficient KO mice 1998). In these studies, genetically prone individuals showed an exaggerated HPA response to challenge by opiate antagonists. This relationship was also found in a recent laboratory study in which two lines of mice selectively bred for high alcohol preference demonstrated exaggerated fear potentiated startle relative to their low-alcohol-preferring counterparts (Barrenha and Chester 2007) . Furthermore, the withdrawal state experienced following chronic EtOH exposure, which is associated with high anxiety, is thought to result in part from downregulation of β-E (Aguirre et al. 1995; Diana et al. 1993; Scanlon et al. 1992; Valdez et al. 2004) . Although these theories are not mutually exclusive, the present data especially support the latter idea by suggesting that β-E modifies sensitivity to both stress and EtOH. Specifically, low β-E leads to increased activity of the HPA axis, and by some unknown mechanism, this deficit facilitates EtOH-mediated anxiolysis.
Although transgenic animals like the ones used in this study can provide useful insight into neural mechanisms underlying behavior, the differences evident in our mouse lines may not be directly related to an effect of missing β-E. For example, in a study of μ-receptor knockout mice (a primary site of β-E action), no differences were found in EtOH-mediated anxiolysis on the plus maze (LaBuda and Fuchs 2001). Furthermore, a review of the literature failed to find precedent for the notion that absent β-E should exaggerate EtOH effects, and the most straightforward interpretation seems unlikely (that β-E acts as a functional EtOH antagonist). It is plausible, however, that the enhanced sensitivity to EtOH's anxiolytic effect seen in β-E deficient mice reflects compensatory changes in related neural systems that occur as a result of absent β-E throughout development. Especially in the case of inbred strains, gene knockout studies can help elucidate the functional interplay between contributing neural factors (e.g., Mogil and Grisel 1998) and epistatic interactions between genes and their products now seems to be the norm rather than the exception in neurobiology. Thus, consequent adaptation of the nervous system to experimental transgenic manipulation may provide a window into the complex systems underlying behavioral states such as anxiety and alcoholism (e.g., Bowers et al. 1999) .
Alcoholism and anxiety disorders are frequently comorbid, and a significant percentage of alcoholics report that they ingest alcohol to reduce anxiety (Compton et al. 2007; Zimmerman et al. 2003) . The fact that low β-E levels have been linked to a higher risk for excessive alcohol intake and alcoholism (Dai et al. 2005; Gianoulakis 1996; Wand et al. 1998 ) and, in our study, to predict higher levels of anxious behavior, suggest that β-E may be a contributing factor to this relationship. Future efforts employing these mice may be useful in elucidating the neural substrates mediating these relationships.
